Search Results - Leiblein, Sabine

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR)

    Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR) by Weber, Axel, Taube, Sylvia, zur Stadt, Udo, Horstmann, Martin, Krohn, Knut, Bradtke, Jutta, Teigler-Schlegel, Andrea, Leiblein, Sabine, Christiansen, Holger

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchymal Iron Loading?

    Highly Elevated Serum Hepcidin in Patients with Acute Myeloid Leukemia prior to and after Allogeneic Hematopoietic Cell Transplantation: Does This Protect from Excessive Parenchyma... by Eisfeld, Ann-Kathrin, Westerman, Mark, Krahl, Rainer, Leiblein, Sabine, Liebert, Uwe Gerd, Hehme, Marianne, Teupser, Daniel, Niederwieser, Dietger, Al-Ali, Haifa Kathrin

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible

    Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible by Vucinic, Vladan, Jentzsch, Madlen, Schwind, Sebastian, Bach, Enrica, Leiblein, Sabine, Remane, Yvonne, Rieprecht, Susanne, Otto, Sandra, Kubasch, Anne-Sophie, Behre, Gerhard, Cross, Michael, Platzbecker, Uwe, Franke, Georg-Nikolaus

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases

    Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therap... by Gerhardt, Kristin, Jentzsch, Madlen, Georgi, Thomas, Sretenović, Aleksandra, Cross, Michael, Bach, Enrica, Monecke, Astrid, Leiblein, Sabine, Hoffmann, Sandra, Todorović, Milena, Bila, Jelena, Sabri, Osama, Schwind, Sebastian, Franke, Georg-Nikolaus, Platzbecker, Uwe, Vučinić, Vladan

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

    Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15 by Hell, Saskia, Jentzsch, Madlen, Franke, Georg-Nikolaus, Jäkel, Nadja, Schulze, Susann, Edelmann, Jeanett, Nenoff, Kolja, Grieb, Nora, Jeremic, Veljko, Cross, Michael, Leiblein, Sabine, Bach, Enrica, Pönisch, Wolfram, Al-Ali, Haifa-Kathrin, Schwind, Sebastian, Platzbecker, Uwe, Lange, Thoralf, Niederwieser, Dietger, Vucinic, Vladan

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: